Date
- Wednesday, 26 June 2024, 15:30 (CEST) - 16:15 (CEST)
Location
- OnlineEuropean Medicines Agency, Amsterdam, the NetherlandsLive broadcast
Event summary
This press briefing will discuss EU actions to tackle shortages of GLP-1 receptor agonists indicated for the treatment of diabetes and in some cases for weight management in patients with obesity or weight-related conditions.
Speakers:
- Emer Cooke, Executive Director, EMA
- Karl Broich, President of the Federal Institute for Drugs and Medical Devices (BfArM)
The two speakers co-chair the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG).
The press briefing will be:
- moderated by Marie-Agnes Heine, Head of Communication, EMA;
- held in English (no translations will be provided);
- streamed live via EMA's YouTube channel, X and LinkedIn page.